Welcome to LookChem.com Sign In|Join Free
  • or
3-BROMO-5-METHOXY-4-PROPOXY-BENZALDEHYDE is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

91335-52-3

Post Buying Request

91335-52-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

91335-52-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 91335-52-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,1,3,3 and 5 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 91335-52:
(7*9)+(6*1)+(5*3)+(4*3)+(3*5)+(2*5)+(1*2)=123
123 % 10 = 3
So 91335-52-3 is a valid CAS Registry Number.
InChI:InChI=1/C11H13BrO3/c1-3-4-15-11-9(12)5-8(7-13)6-10(11)14-2/h5-7H,3-4H2,1-2H3

91335-52-3Relevant academic research and scientific papers

Asymmetrical 2,6-bis(benzylidene)cyclohexanones: Synthesis, cytotoxic activity and QSAR study

Nakhjiri, Maryam,Safavi, Maliheh,Alipour, Eskandar,Emami, Saeed,Atash, Amir Farzin,Jafari-Zavareh, Mona,Ardestani, Sussan K.,Khoshneviszadeh, Mehdi,Foroumadi, Alireza,Shafiee, Abbas

, p. 113 - 123 (2012/07/03)

In order to develop novel anti-cancer agents, a series of asymmetrical 2,6-bis (benzylidene)cyclohexanone derivatives containing nitrobenzylidene moiety were synthesized and their cytotoxic activity were determined in vitro against MDA-MB 231, MCF-7 and SK-N-MC cell lines using MTT assay. Among the tested compounds, the highest activity against MDA-MB 231 cells was achieved by 2-(3-bromo-5-methoxy-4-propoxybenzylidene)-6-(2-nitrobenzylidene)cyclohexanone (compound 5d). Whereas, compound 5j (the 3-nitro analog of compound 5d) was the most potent compound against MCF-7 and SK-N-MC cell lines. The results indicated that the cytotoxic activity profile against different tumor cells can be optimized by desired 4-alkoxy-3-bromo-5-methoxybenzylidene scaffold.

1,3-DIARYL CYCLOPENTANES AND DERIVATIVES THEREOF AS PAF ANTAGONISTS

-

, (2008/06/13)

Novel 1,3-diaryl cyclopentanes of the following general formula were prepared. STR1 These compounds were found to have potent and specific PAF (Platelet Activating Factor) antagonistic activities and as such useful in the treatment or amelioration of various diseases or disorders mediate by the PAF, for example, hypotension, inflammation, nephritis, stroke and other cardiovascular disorders, asthma, allergic and skin diseases, peptic or stomach ulcer, shock, lung edema, psoriasis, adult respiratory distress syndrome, pain including dental pain, and aggregation of platelets.

New 1,3-diaryl cyclopentanes and derivatives thereof as paf antagonists

-

, (2008/06/13)

Novel 1,3-Diaryl cyclopentanes were prepared. These compounds were found to have potent and specific PAF (Platelet Activating Factor) antagonistic activities and as such useful in the treatment or amelioration of various diseases or disorders mediated by

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 91335-52-3